IFIBYNE   05513
INSTITUTO DE FISIOLOGIA, BIOLOGIA MOLECULAR Y NEUROCIENCIAS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
The SR protein SRSF1 at different levels of the SUMO conjugation pathway
Autor/es:
RISSO, GUILLERMO; PELISCH FEDERICO; POZZI, BERTA; SREBROW ANABELLA
Lugar:
IGUAZU
Reunión:
Congreso; Gene Expression and RNA Processing; 2011
Institución organizadora:
ICGEB, ANPCyT y CONICET
Resumen:
FROM THE ROLE OF SRSF1 AS A COMPONENT OF THE SUMO CONJUGATION PATHWAY
TO THE INVOLVEMENT OF AKT SUMOYLATION IN SPLICING REGULATION
G. Risso, F. Pelisch, B. Pozzi and A. Srebrow
Laboratorio de Fisiología y Biología Molecular, IFIBYNE-CONICET, FCEyN-UBA, Buenos Aires,
Argentina
E-mail: guillermorisso@fbmc.fcen.uba.ar
A cell generates complex responses upon a variety of stimuli that it receives within a multicellular
organism. Our lab studies the molecular mechanisms by which different extracellular cues activate
signaling pathways that control splicing factor activity at different steps of gene expression regulation.
Based on our previous results demonstrating that: i) Pi3K/Akt pathway regulates alternative splicing;
ii) Akt phosphorylates SR proteins, in particular SRSF1 (previously known as SF2/ASF); and iii)
SRSF1 regulates SUMOylation, we proposed to explore a possible regulatory feedback loop among the
components of the Pi3K/Akt/SR protein axis. We found that Akt1 and Akt2 are SUMOylation targets,
as demonstrated by purification of SUMOylated proteins from His-SUMO over-expressing cells by
Ni2+ affinity chromatography. When evaluating the effect of over-expressing different SUMO E3
ligases on Akt SUMOylation, we observed that SRSF1 is capable of regulating Akt SUMOylation
levels. Furthermore, we found that SRSF1 is also a SUMOylation target and, by using SRSF1 deletion
mutants we mapped the SUMO conjugation residue to the RRM2 domain. We are currently exploring
the consequences of the previously unknown post-translational modification of SRSF1 and Akt by
SUMO conjugation on the different activities of these two proteins, focusing on alternative splicing
regulation.